Wishart J M, Hodge J L, Greig D E
N Z Med J. 1981 Oct 28;94(694):307-8.
In an open trial, eight patients with psoriasis took part in a four-month study to evaluate the effect of a new oral synthetic retinoid Ro-10-9359 (Tigason). All patients improved on the treatment, although one had side effects severe enough to force dosage reduction with less satisfactory control.